69 related articles for article (PubMed ID: 24803308)
1. Age-related differences in urinary 11-dehydroxythromboxane B2 between infants, children, and adolescents: another example of developmental hemostasis?
Varnell CD; Goldstein SL; Yee DL; Teruya J; Guyer KE; Siddiqui S; Jefferies JL
Pediatr Blood Cancer; 2014 Nov; 61(11):2074-6. PubMed ID: 24803308
[TBL] [Abstract][Full Text] [Related]
2. Monitoring thromboxane in body fluids: a specific ELISA for 11-dehydrothromboxane B2 using a monoclonal antibody.
Reinke M
Am J Physiol; 1992 May; 262(5 Pt 1):E658-62. PubMed ID: 1590375
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the major urinary thromboxane metabolites, 2,3-dinorthromboxane B2 and 11-dehydrothromboxane B2, by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry.
Uedelhoven WM; Meese CO; Weber PC
J Chromatogr; 1989 Dec; 497():1-16. PubMed ID: 2625446
[TBL] [Abstract][Full Text] [Related]
4. Acetylsalicylic acid therapy: influence of metformin use and other variables on urinary 11-dehydrothromboxane B2 levels.
Gonçalves LH; Silva MV; Duarte RC; Dusse LM; Fernandes AP; Bosco AA; Gomes KB; Carvalho Md
Clin Chim Acta; 2014 Feb; 429():76-8. PubMed ID: 24316050
[TBL] [Abstract][Full Text] [Related]
5. Radioimmunoassay of 11-dehydrothromboxane B2 in human plasma and urine.
Ciabattoni G; Maclouf J; Catella F; FitzGerald GA; Patrono C
Biochim Biophys Acta; 1987 Apr; 918(3):293-7. PubMed ID: 3567215
[TBL] [Abstract][Full Text] [Related]
6. Urinary 11-dehydrothromboxane B2 aspirin efficacy testing is sensitive to perioperative inflammation in pediatric solid-organ transplant patients.
Boucher AA; Francisco BJ; Pfeiffer A; Martin M; Martin J; Shova A; Nathan JD; Tiao GM; Luchtman-Jones L
Pediatr Blood Cancer; 2022 Feb; 69(2):e29413. PubMed ID: 34676969
[TBL] [Abstract][Full Text] [Related]
7. Changes in plasma and urinary 11-dehydrothromboxane B2 in healthy subjects produced by oral CS-518, a novel thromboxane synthase inhibitor.
Uematsu T; Takasaki W; Kosuge K; Wada K; Matsuno H; Tanaka Y; Yamamura N; Nakashima M
Eur J Clin Pharmacol; 1993; 45(3):283-6. PubMed ID: 8276056
[TBL] [Abstract][Full Text] [Related]
8. Comparison of aspirin response measured by urinary 11-dehydrothromboxane B2 and VerifyNow aspirin assay in patients with ischemic stroke.
Dharmasaroja PA; Sae-Lim S
J Stroke Cerebrovasc Dis; 2014; 23(5):953-7. PubMed ID: 24126290
[TBL] [Abstract][Full Text] [Related]
9. Solid-phase extraction of urinary 11-dehydrothromboxane B2 for reliable determination with radioimmunoassay.
Riutta A; Mucha I; Vapaatalo H
Anal Biochem; 1992 May; 202(2):299-305. PubMed ID: 1519756
[TBL] [Abstract][Full Text] [Related]
10. Risk factors for carotid atherosclerosis and platelet activation.
Uyama O; Matsui Y; Shimizu S; Michishita H; Sugita M
Jpn Circ J; 1994 Jun; 58(6):409-15. PubMed ID: 8065012
[TBL] [Abstract][Full Text] [Related]
11. Aspirin resistance in Indian patients with coronary artery disease and cardiovascular events.
Thomson VS; John B; George P; Joseph G; Jose J
J Postgrad Med; 2009; 55(4):252-6. PubMed ID: 20083870
[TBL] [Abstract][Full Text] [Related]
12. Effects of different doses, enteric-coated preparation of aspirin, and sex on urinary 11-dehydrothromboxane B2 in healthy volunteers.
Dharmasaroja PA; Sae-Lim S
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):649-52. PubMed ID: 20689403
[TBL] [Abstract][Full Text] [Related]
13. Monitoring aspirin therapy in children after interventional cardiac catheterization: laboratory measures, dose response, and clinical outcomes.
Schmugge M; Speer O; Kroiss S; Knirsch W; Kretschmar O; Rand ML; Albisetti M
Eur J Pediatr; 2015 Jul; 174(7):933-41. PubMed ID: 25589198
[TBL] [Abstract][Full Text] [Related]
14. GC/MS/MS quantification of 11-dehydrothromboxane B2 in human urine.
Ferretti A; Flanagan VP; Maida EJ
Prostaglandins Leukot Essent Fatty Acids; 1992 Aug; 46(4):271-5. PubMed ID: 1409763
[TBL] [Abstract][Full Text] [Related]
15. Studies on the urinary excretion of thromboxane B2 in Zellweger patients and control subjects: evidence for a major role for peroxisomes in the beta-oxidative chain-shortening of thromboxane B2.
de Waart DR; Koomen GC; Wanders RJ
Biochim Biophys Acta; 1994 Apr; 1226(1):44-8. PubMed ID: 8155738
[TBL] [Abstract][Full Text] [Related]
16. [Correlation between the clinical effects of Seratrodast and the level of 11-dehydrothromboxane B2 in urine/sputum in bronchial asthma patients].
Muramatsu H; Kotajima R; Sato T
Arerugi; 2001 Jun; 50(6):540-6. PubMed ID: 11517517
[TBL] [Abstract][Full Text] [Related]
17. Comparison between urinary 11-dehydrothromboxane B2 detection and platelet Light Transmission Aggregometry (LTA) assays for evaluating aspirin response in elderly patients with coronary artery disease.
Liu T; Zhang J; Chen X; Feng X; Fu SW; McCaffrey TA; Liu M
Gene; 2015 Oct; 571(1):23-7. PubMed ID: 26095809
[TBL] [Abstract][Full Text] [Related]
18. Enzyme immunoassay of human plasma 11-dehydrothromboxane B2.
Takasaki W; Nakagawa A; Tanaka Y; Nakamura K; Shindo H; Hayashi Y; Yamamoto S
Thromb Res; 1991 Aug; 63(3):331-41. PubMed ID: 1957275
[TBL] [Abstract][Full Text] [Related]
19. Analysis of urinary 11-dehydrothromboxane B2 in patients with occluded retinal vein using GC/SIM.
Yamanobe S; Nakagawa Y; Hishinuma T; Mizugaki M; Tamai M
Prostaglandins Leukot Essent Fatty Acids; 1998 Jan; 58(1):65-8. PubMed ID: 9482168
[TBL] [Abstract][Full Text] [Related]
20. Urinary thromboxane B2 and 2,3-dinor-thromboxane B2 in the neonate born at full-term age.
Van Geet C; Arnout J; Eggermont E; Vermylen J
Eicosanoids; 1990; 3(1):39-43. PubMed ID: 2328133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
